Provided by Tiger Fintech (Singapore) Pte. Ltd.

Applied Therapeutics Inc.

0.4349
+0.02486.05%
Post-market: 0.43500.0001+0.02%19:59 EDT
Volume:6.26M
Turnover:2.68M
Market Cap:50.60M
PE:-0.30
High:0.4504
Open:0.4100
Low:0.4000
Close:0.4101
Loading ...

Top Premarket Decliners

MT Newswires Live
·
29 Nov 2024

Applied Therapeutics CRL a ‘major setback,’ says William Blair

TIPRANKS
·
29 Nov 2024

Stock Track | Applied Therapeutics Plunges 71.76% Pre-market as RBC Downgrades, Slashes Price Target

Stock Track
·
29 Nov 2024

U.S. RESEARCH ROUNDUP-Applied Therapeutics, Brown-Forman, Ulta Beauty

Reuters
·
29 Nov 2024

Applied Therapeutics Inc : Baird Cuts Target Price to $5 From $14

THOMSON REUTERS
·
29 Nov 2024

RBC Downgrades Applied Therapeutics to Sector Perform From Outperform, Cuts Price Target to $4 From $12, Keeps Speculative Risk

MT Newswires Live
·
29 Nov 2024

Applied Therapeutics Inc : RBC Cuts to Sector Perform From Outperform; Cuts Target Price to $4 From $12

THOMSON REUTERS
·
29 Nov 2024

Applied Therapeutics Shares Drop 73.1% Premarket After U.S. FDA Declines to Approve Co's Genetic Disease Drug

THOMSON REUTERS
·
29 Nov 2024

24H|Nvidia and ASML Rise 1%; MicroStrategy Gains 4%; Archer Aviation Jumps 10%; Applied Therapeutics Plunges 74%

Tiger Newspress
·
29 Nov 2024

APLT Stock Plunges 77% After FDA Issues CRL for Galactosemia Drug NDA

Zacks
·
28 Nov 2024

BRIEF-Applied Therapeutics Receives Complete Response Letter From U.S. FDA Regarding New Drug Application For Govorestat

Reuters
·
28 Nov 2024

Applied Therapeutics Down 76% After Hours on FDA Complete Response Letter

Dow Jones
·
28 Nov 2024

BUZZ-Applied Therapeutics plummets after FDA declines to approve genetic disease drug

Reuters
·
28 Nov 2024

US FDA Rejects Applied Therapeutics' New Drug Application for Govorestat in Classic Galactosemia

MT Newswires Live
·
28 Nov 2024

Applied Therapeutics Shares Down 82.73% at $1.48 in Extended Trade After US FDA Declines to Approve Genetic Disease Drug

THOMSON REUTERS
·
28 Nov 2024

Applied Therapeutics trading resumes

TIPRANKS
·
28 Nov 2024

Applied Therapeutics Receives FDA Complete Response Letter for Govorestat New Drug Application

Dow Jones
·
28 Nov 2024

Applied Therapeutics’ NDA for govorestat receives negative response from FDA

TIPRANKS
·
28 Nov 2024

US FDA declines to approve Applied Therapeutics' genetic disease drug

Reuters
·
28 Nov 2024

Applied Therapeutics Inc - Expects to Submit an Nda Early in Q1 of 2025

THOMSON REUTERS
·
28 Nov 2024